glp-1 support platforms private companies | Appetite support for cravings and fullness control Market Overview: GLP-1 Agonists and
Description
doi:10.1056/NEJMoa1504720 49
Zepbound is a prescription obesity drug containing tirzepatide, manufactured by Eli Lilly and approved for chronic weight management after receiving FDA approval for use in eligible adults with obesity or overweight with certain related conditions
Companies Covered in GLP-1 Receptor Agonist Market Eli Lilly and Company Sanofi Novo-Nordisk A/S AstraZeneca Amgen, Inc
For example, glucagon-like peptide-1 agonists (GLP-1) are normally used for the treatment of type 2 diabetes mellitus, obesity, and cardiovascular diseases
